| 1831 | Composite, with 2 known prime factors. Cofactor is composite. Trial Factored to 268 TF target 244 |
| Factored | |
| ECM | | Digits | B1 | Curves |
|---|
| 25 | 50000 | 280 / 280 | | 30 | 250000 | 640 / 640 | | 35 | 1000000 | 1566 / 1566 | | 40 | 3000000 | 4588 / 4588 | | 45 | 11000000 | 9201 / 9201 | | 50 | 44000000 | 16550 / 16550 | | 55 | 110000000 | 40830 / 40830 | | 60 | 260000000 | 105362 / 105362 | | 65 | 800000000 | 65867 / 194238 |
Estimated T-Level: 61.7 ⓘ TF below 2^200 is very unlikely to find new factors due to ECM effort. |
| PRP Cofactor | | Status | Proof | Date | User | Residue | Number of
known factors | Shift | Type | Base |
|---|
| Verified | No proof (small exponent) | 2017-09-21 | Oliver Kruse | 9B52F38DC9035A8E | 2 | 0 | 1 | 3 | | Verified | No proof (small exponent) | 2017-10-12 | kkmrkkblmbrbk | 9B52F38DC9035A8E | 2 | 1649 | 1 | 3 | | Verified | No proof (small exponent) | 2020-04-17 | Oliver Kruse | EFE491714CD0E39E | 2 | 1648 | 5 | 3 | | Verified | No proof (small exponent) | 2020-08-12 | _p95holder_ | EFE491714CD0E39E | 2 | 1245 | 5 | 3 |
|
| History | | Date | User | Type | Result |
|---|
| 2022-10-24 | mikr | NF-PM1 | B1=500000000000, B2=3217559319645030360 | | 2021-07-24 | ViliamF | NF-PP1 | Start=2/7, B1=1000000000, B2=221000000000 | | 2020-08-12 | _p95holder_ | C-PRP | M1831/202081830521/21919356186601 : EFE491714CD0E39E | | 2020-04-17 | Oliver Kruse | C-PRP | M1831/202081830521/21919356186601 : EFE491714CD0E39E | | 2017-10-12 | kkmrkkblmbrbk | C-PRP | M1831/202081830521/21919356186601 : 9B52F38DC9035A8E | | 2017-09-21 | Oliver Kruse | C-PRP | M1831/202081830521/21919356186601 : 9B52F38DC9035A8E | | 2017-09-21 | Oliver Kruse | C-PRP | M1831/202081830521/21919356186601 : 9B52F38DC9035A8E | | 2016-09-07 | kkmrkkblmbrbk | NF-PM1 | B1=1000000000, B2=100000000000, E=12 | | 1999-05-02 | -anonymous- | F-PM1 | Factor: 21919356186601 | | 1999-03-26 | -anonymous- | F-PM1 | Factor: 21919356186601 | | 1999-03-15 | -anonymous- | F-PM1 | Factor: 21919356186601 |
|
